ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58575 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58575; 2) Community: the network communities that were significantly associated with the response to NSC 58575; 3) Molecule: the relationships between components within communities and NSC 58575; 4) MDR: the compounds that were significantly associated with the NSC 58575.

NSC Compound Enrichment Correlation
NSC 711611 Null 0.0102962192514438 0.37332437
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0102962192514438 0.50018733
NSC 730563 Miliusane A 0.0102962192514438 0.31417274
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0102962192514438 -0.10861163
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0102962192514438 0.65564788
NSC 741942 Null 0.0102962192514438 0.5012373
NSC 756698 Clomiphene citrate (USAN) 0.0102962192514438 0.2144815
NSC 127128 Null 0.0102962192514439 -0.13534168
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0102962192514439 0.42303453
NSC 290193 CYCLOSPORIN A 0.0102962192514439 0.46621725
Total:99  Current:27    [First] [Prev] [Next] [Last]